Thank You!

We’ll get back to you
as soon as possible.
In the meantime, take a look
at the related readings.


Related readings


EU HTA Regulation: What’s changing & why it matters

Join Chantal & Sigrid on Thursday, June 27th, 2024, at 14:00 BST / 15:00 CEST / 9:00 EDT for the first episode of our webinar series on the upcoming European Health Technology Assessment (HTA) regulation.

Encouraging Rare Disease Medicines Development: MHRA’s Supportive Measures

Developing treatments for rare diseases poses unique challenges due to limited prevalence. However, the MHRA is incentivizing medicine development in this area.

Get to know our experts – Michael Cooper

In this article, we shine the spotlight on Michael Cooper, Senior Consultant at NDA

Contact Us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World

This field is for validation purposes and should be left unchanged.